The Impact of Pain Neuroscience Education on Physical Therapy Students' Knowledge, Attitudes, Beliefs, and Behaviors Towards Pain: A Randomized Controlled Trial

May 13, 2026 updated by: Ahmad Muhsen, The Hashemite University
This study investigates the effect of pain neuroscience education (PNE) on pain knowledge, attitudes, beliefs and behaviors among undergraduate physiotherapy students in Jordan

Study Overview

Detailed Description

Physiotherapy students at the Hashemite University will be randomly assigned into either pain neuroscience education or control lectures groups. Both groups will receive a 70-min didactic group-lecture. The control group will receive education about red-flags which are special screening questions for serious pathology. The red-flags education will discuss tissue pathology and triage for back pain classification. Neurophysiology and the biopsychosocial mode will not be discussed. The intervention group will receive a PNE lecture. All primary and secondary outcome measures consist of validated questionnaires (e.g., RNPQ, HC-PAIRS), except for the study-specific red-flags knowledge test; the study-specific case vignette assessing guideline-concordant low back pain recommendations underwent validation testing before participant recruitment.

Study Type

Interventional

Enrollment (Actual)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Zarqa Governorate
      • Zarqa, Zarqa Governorate, Jordan, 13133
        • The Hashemite University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Physiotherapy undergraduate students at the Hashemite University

Exclusion Criteria:

  • Previous formal pain education
  • Enrolled in a clinical practice module

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Pain Neuroscience Education
The intervention group will receive a lecture of 70min duration on pain neuroscience. The objective of this educational session is to educate students that pain can be overprotective, and that nociceptive transmission can be heavily influenced by central sensitisation (sensitivity of the central nervous system) as well as the thoughts and beliefs of the individual. The session used drawings, stories and metaphors to depict the underlying neuroscience of pain, and current pain theory.
Active Comparator: Red Flags Education
The control group received an education session of red flags. Red flags form part of routine subjective practice for therapists as a process of screening serious or potentially sinister pathologies. Sign and symptoms for such pathologies include history of cancer, systemic symptoms such as fever or unexplained weight loss, and saddle analgesia. The red flag session will not include the neuroscience of pain.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Revised Pain Neurophysiology Questionnaire (RNPQ)
Time Frame: Before and immediately after and 6 months after the education session
The 12-item RNPQ will be used to assess knowledge of pain neurophysiology. Responses are marked yes, no or undecided. One point is awarded for correct answers. Scores range from 0 to 12, with high scores indicating good knowledge.
Before and immediately after and 6 months after the education session
The modified HC-PAIRS
Time Frame: Prior to and immediately and 6 months after the education session
The modified HC-PAIRS (Health Care Providers' Pain and Impairment Relationship Scale will be used to measure attitudes and beliefs towards patients with chronic pain and their ability to function. This 13-item questionnaire uses a 7-point Likert scale (strongly disagree to strongly agree). Scores range from 13 to 91 with lower scores suggesting more positive attitudes.
Prior to and immediately and 6 months after the education session

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Guideline-concordant low back pain recommendations assessed using a case vignette
Time Frame: Baseline, immediately after the education session, and 6 months after the education session.
A case vignette will be used to assess participants' vignette-based clinical recommendations for a patient with non-specific low back pain. Participants will answer four multiple-choice questions addressing recommendations regarding usual daily activities, work, exercise, and bed rest. Each domain will be scored as guideline-concordant or non-guideline-concordant according to contemporary low back pain guideline recommendations. The total number of guideline-concordant recommendations will be calculated, with possible scores ranging from 0 to 4; higher scores indicate more guideline-concordant recommendations. The percentage of guideline-concordant recommendations may also be reported. The vignette was developed for this study and psychometrically evaluated before participant recruitment and before its use as a trial outcome, including expert review for content validity, cognitive pretesting, construct validity assessment, test-retest reliability, and measurement error analysis.
Baseline, immediately after the education session, and 6 months after the education session.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
LBP Red-Flags Knowledge Quiz (10-item)
Time Frame: Baseline, Post, and 6 months after lecture control session
It is a 10-item quiz, with yes/no answers that assesses knowledge of red-flags. Scores range from 0 to 10. This questionnaire was developed within our team. This is to provide attention-matched control content and to support participant blinding to the vignette outcome. This tool is developed de novo to provide attention-matched control content and to evaluate knowledge of red-flag indicators of serious spinal pathology. This is a de novo instrument developed and face validated for this trial. The face validation process, conducted prior to participant recruitment.
Baseline, Post, and 6 months after lecture control session

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 15, 2024

Primary Completion (Actual)

May 13, 2026

Study Completion (Actual)

May 13, 2026

Study Registration Dates

First Submitted

February 6, 2025

First Submitted That Met QC Criteria

February 6, 2025

First Posted (Actual)

February 11, 2025

Study Record Updates

Last Update Posted (Actual)

May 15, 2026

Last Update Submitted That Met QC Criteria

May 13, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

After completion of the data collection, it will be analysed and then interpreted. I will provide you with the study results and recommendations upon completion.

IPD Sharing Time Frame

After being published, the dataset and/or the statistical analyses will be made available for interested researchers upon reasonable request.

IPD Sharing Access Criteria

After being published, the dataset and/or the statistical analyses will be made available for interested researchers upon reasonable request.

IPD Sharing Supporting Information Type

  • SAP

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy Subjects

Clinical Trials on Pain Neuroscience Education

Subscribe